Gilotrif Tablet, Film Coated
Product Images NDC 0597-0137

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gilotrif (NDC 0597-0137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gilotrif 01

Chemical structure diagram of afatinib, the active ingredient in Gilotrif. The structure shows a fused ring system with chlorine and fluorine substitutions, and functional groups including carboxylic acids, amides, and ether.*

FDA Label Image

Gilotrif 02

A Kaplan-Meier survival curve graph comparing progression-free survival probability over time (in months) between Afatinib 40 mg and a Pe500+Cis75 treatment group. The graph shows estimated progression-free survival probabilities with median values and statistical analysis including hazard ratio, confidence interval, and log-rank test p-value.*

FDA Label Image

Gilotrif 03

A forest plot comparing median progression-free survival (PFS) and overall survival (OS) in months for Gilotrif versus Pem/Cis treatment across three EGFR mutation categories (Del 19/L858R, Del 19, L858R). The plot displays hazard ratios (HR) with confidence intervals, showing survival data favoring Gilotrif in the PFS comparisons.*

FDA Label Image

Gilotrif 04

A Kaplan-Meier survival curve graph comparing estimated overall survival probability over time (in months) between two drugs, Afatinib and Erlotinib. The x-axis represents time of overall survival in months (up to 30 months), and the y-axis shows the estimated overall survival probability from 0 to 1. The graph includes the number of patients at risk for each drug at various time points.*

FDA Label Image

Gilotrif 04a

FDA Label Image

Gilotrif 05

Gilotrif 20 mg afatinib tablets film-coated oral tablets packaging label. The box contains 30 tablets and is distributed by Boehringer Ingelheim Pharmaceuticals, Inc. It includes storage instructions, dosage warnings, and contact information with QR codes for more details. The label highlights the active ingredient afatinib at 20 mg strength.*

FDA Label Image

Gilotrif 06

The packaging label for Gilotrif 30 mg film-coated tablets features the proprietary name Gilotrif with the generic name afatinib tablets. The label indicates a 30-tablet count and includes storage instructions to keep the medication at controlled room temperature, protected from light and humidity. Distributed by Boehringer Ingelheim Pharmaceuticals, the box also has a barcode, QR codes, and contact information for further prescribing details.*

FDA Label Image

Gilotrif 07

Gilotrif 40 mg (afatinib tablets) film-coated tablets packaging label for oral use. The carton indicates 30 tablets per bottle and includes manufacturer and distributor information for Boehringer Ingelheim Pharmaceuticals, Inc. Storage instructions include protecting from light and high humidity and recommended temperature ranges. The label displays NDC 0597-0138-30 and includes QR codes for additional prescribing and healthcare provider information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.